NUON CO., LTD.
KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2010 and listed on KOSDAQ in 2010, Nuon is a health functional food and household product company. It manufactures and sells individually recognized functional ingredients such as the fat-reduction ingredient Cissus, joint-health ingredients Gwanjeollyeok and Gwanjeol Plus gajac extract, the immune-boosting French Immune Echinacea, and the memory-improving Dr. Esther, along with household and cosmetic products under its Sallimbaekseo brand. 2025 revenue was led by Sallimbaekseo household products at 51.8%, Cissus at 24.6%, other merchandise sales (including Magic Kid) at 13.6%, and French Immune Echinacea at 4.9%, while its special-purpose machinery (vacuum deposition equipment) segment discontinued operations on December 5, 2025.
Products & technology
- Cissus (Pil/Hyu/Su/Sports Burning Water)individually recognized fat-reduction functional food ingredient
- Gwanjeollyeokindividually recognized joint/cartilage health ingredient (Boswellia extract)
- Gwanjeol Plus gajac extractindividually recognized joint/cartilage health ingredient
- Dr. Esther (Hyeonsam Plus Up)individually recognized memory-improvement ingredient
- French Immune Echinaceaindividually recognized immune-boosting ingredient
- Diglomera (Diglofit)individually recognized fat-reduction ingredient
- Magic Kidchildren's height growth support product
- Sallimbaekseohousehold, hair, body, and cosmetic products brand
Regulatory approvals
data.go.kr1 Korean MFDS device approvals · 2017
- MFDSGraft/prosthesis, biomaterialRevoked2017-03-20Product approval · Class 4제허 17-199 호
Clinical trials
data.go.kr1 MFDS clinical trial authorisations · 2014 (Phase 2b 1)
- Phase 2bDS-14042014-10-23
1 trial site
R&D and key agreements
Source: DART corporate disclosure개별인정형 기능성 원료 개발 · 체지방감소·관절건강·면역증진·기억력개선 등 · 지속(2018.12 시서스추출물 최초 허가 이후 확대) · In-house R&D center's material research and regulatory teams obtain MFDS individually recognized ingredient approvals through animal and human clinical studies
Companies approved for the same productsHealthcare Infrastructure
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.
Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.
KOSDAQ-listed aesthetics exporter behind HA skin booster CANDOLOV SERUM and filler brands COLENA and CANDORLOV.
Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.
Spun off and listed in 2013, Chong Kun Dang out-licensed its HDAC6 inhibitor CKD-510 to Novartis in a deal worth about KRW 1.7 trillion.
KOSDAQ-listed pharmaceutical company producing a diverse, low-volume portfolio of metabolic disease drugs, wellness injections, and veterinary medicines.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition